scholarly journals Diagnosis and treatment of right ventricular dysfunction in congenital heart disease

2020 ◽  
Vol 10 (5) ◽  
pp. 1625-1645
Author(s):  
Béatrice Santens ◽  
Alexander Van De Bruaene ◽  
Pieter De Meester ◽  
Michele D’Alto ◽  
Sushma Reddy ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Right Ventricular ◽  
Congenital Heart ◽  
Ventricular Dysfunction ◽  
Right Ventricular Dysfunction ◽  
Diagnosis And Treatment

scholarly journals Volume load-induced right ventricular dysfunction in animal models: insights in a translational gap in congenital heart disease

2017 ◽  
Vol 20 (4) ◽  
pp. 808-812 ◽  
Author(s):  
Guido P.L. Bossers ◽  
Quint A.J. Hagdorn ◽  
Mark Jan Ploegstra ◽  
Marinus A.J. Borgdorff ◽  
Herman H.W. Silljé ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Animal Models ◽  
Right Ventricular ◽  
Congenital Heart ◽  
Ventricular Dysfunction ◽  
Right Ventricular Dysfunction ◽  
Volume Load

scholarly journals Autologous skeletal myoblast patch implantation prevents the deterioration of myocardial ischemia and right heart dysfunction in a pressure-overloaded right heart porcine model

PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0247381
Author(s):  
Kanta Araki ◽  
Shigeru Miyagawa ◽  
Takuji Kawamura ◽  
Ryo Ishii ◽  
Tadashi Watabe ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Myocardial Ischemia ◽  
Right Ventricular ◽  
Congenital Heart ◽  
Porcine Model ◽  
Ventricular Dysfunction ◽  
Right Ventricular Dysfunction ◽  
Skeletal Myoblast ◽  
Right Heart ◽  
Angiogenic Effect

Right ventricular dysfunction is a predictor for worse outcomes in patients with congenital heart disease. Myocardial ischemia is primarily associated with right ventricular dysfunction in patients with congenital heart disease and may be a therapeutic target for right ventricular dysfunction. Previously, autologous skeletal myoblast patch therapy showed an angiogenic effect for left ventricular dysfunction through cytokine paracrine effects; however, its efficacy in right ventricular dysfunction has not been evaluated. Thus, this study aimed to evaluate the angiogenic effect of autologous skeletal myoblast patch therapy and amelioration of metabolic and functional dysfunction, in a pressure-overloaded right heart porcine model. Pulmonary artery stenosis was induced by a vascular occluder in minipigs; after two months, autologous skeletal myoblast patch implantation on the right ventricular free wall was performed (n = 6). The control minipigs underwent a sham operation (n = 6). The autologous skeletal myoblast patch therapy alleviated right ventricular dilatation and ameliorated right ventricular systolic and diastolic dysfunction. 11C-acetate kinetic analysis using positron emission tomography showed improvement in myocardial oxidative metabolism and myocardial flow reserve after cell patch implantation. On histopathology, a higher capillary density and vascular maturity with reduction of myocardial ischemia were observed after patch implantation. Furthermore, analysis of mRNA expression revealed that the angiogenic markers were upregulated, and ischemic markers were downregulated after patch implantation. Thus, autologous skeletal myoblast patch therapy ameliorated metabolic and functional dysfunction in a pressure-overloaded right heart porcine model, by alleviating myocardial ischemia through angiogenesis.

Sign in / Sign up

Export Citation Format

Share Document